Literature DB >> 22633649

Recombinant LH supplementation in women of 35 years and older undergoing IVF?

Tamar E König, Lisette E E van der Houwen, Cornelis B Lambalk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22633649     DOI： 10.1016/j.fertnstert.2012.04.048

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  3 in total

1.  Analysis of androgen receptor and anti-Müllerian hormone pathways in human granulosa cells under luteinizing hormone treatment.

Authors:  Kuo-Chung Lan; Shiuh Young Chang; Fu-Jen Huang; Hsin-Jung Lin; Ching-Yuang Lin; Ko-En Huang; Hong-Yo Kang
Journal:  Reprod Biol Endocrinol       Date:  2013-02-21       Impact factor: 5.211

Review 2.  A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology.

Authors:  Diego Ezcurra; Peter Humaidan
Journal:  Reprod Biol Endocrinol       Date:  2014-10-03       Impact factor: 5.211

3.  Pretreatment with oral contraceptive pills to identify poor responders that may benefit from rLH supplementation during GnRH-antagonist treatment for IVF: A pilot perspective study proposal.

Authors:  Salvatore Gizzo; Alessandra Andrisani; Marco Noventa; Michele Gangemi; Giovanni Battista Nardelli; Guido Ambrosini
Journal:  Exp Ther Med       Date:  2015-09-08       Impact factor: 2.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.